Efficacy and safety of tirzepatide as novel treatment for type 2 diabetes: A systematic review and meta-analysis of randomized clinical trials
Author:
Publisher
Elsevier BV
Subject
General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference33 articles.
1. Definition, classification and diagnosis of diabetes mellitus;Petersmann;Exp Clin Endocrinol Diabetes,2019
2. 2019 update to: management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Buse;Diabetologia,2020
3. Effect of glucagon-like peptide-1 receptor agonists on body weight in adults with obesity without diabetes mellitus-a systematic review and meta-analysis of randomized control trials;Iqbal;Obes Rev,2022
4. GLP-1 receptor agonists: an updated review of head-to-head clinical studies;Trujillo;Ther Adv Endocrinol Metab,2021
5. Pre-admission glucagon-like peptide-1 receptor agonist (GLP-1RA) and mortality from coronavirus disease 2019 (Covid-19): a systematic review, meta-analysis, and meta-regression;Hariyanto;Diabetes Res Clin Pract,2021
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. G protein-Coupled Receptor Associated Sorting Protein GASP1 mediated trafficking of the Glucagon Like Peptide-1 Receptor contributes to the development of tolerance to incretin drugs;2024-08-10
2. Data mining study on adverse events of tirzepatide based on FAERS database;Expert Opinion on Drug Safety;2024-07-15
3. Obesity medications: A narrative review of current and emerging agents;Osteoarthritis and Cartilage Open;2024-06
4. Once-weekly insulin as novel treatment for type 2 diabetes mellitus: A systematic review and meta-analysis of randomized clinical trials;Diabetes Research and Clinical Practice;2024-05
5. Tirzepatide cardiovascular benefits and adverse events assessment: a Bayesian network meta-analysis;2024-04-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3